Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Growth factor activation of the phosphatidylinositol 3-kinase (PI3K)-AKT pathway has been shown to activate the estrogen receptor (ER) alpha and to mediate tamoxifen resistance in breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP234866.RAwYbpag8C72z39Un6uyVmDy49aeJgW0Xdh7w7CxCZGAI130_assertion description "[Growth factor activation of the phosphatidylinositol 3-kinase (PI3K)-AKT pathway has been shown to activate the estrogen receptor (ER) alpha and to mediate tamoxifen resistance in breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP234866.RAwYbpag8C72z39Un6uyVmDy49aeJgW0Xdh7w7CxCZGAI130_provenance.
• assertion description "[Growth factor activation of the phosphatidylinositol 3-kinase (PI3K)-AKT pathway has been shown to activate the estrogen receptor (ER) alpha and to mediate tamoxifen resistance in breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Growth factor activation of the phosphatidylinositol 3-kinase (PI3K)-AKT pathway has been shown to activate the estrogen receptor (ER) alpha and to mediate tamoxifen resistance in breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Growth factor activation of the phosphatidylinositol 3-kinase (PI3K)-AKT pathway has been shown to activate the estrogen receptor (ER) alpha and to mediate tamoxifen resistance in breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Growth factor activation of the phosphatidylinositol 3-kinase (PI3K)-AKT pathway has been shown to activate the estrogen receptor (ER) alpha and to mediate tamoxifen resistance in breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Growth factor activation of the phosphatidylinositol 3-kinase (PI3K)-AKT pathway has been shown to activate the estrogen receptor (ER) alpha and to mediate tamoxifen resistance in breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Growth factor activation of the phosphatidylinositol 3-kinase (PI3K)-AKT pathway has been shown to activate the estrogen receptor (ER) alpha and to mediate tamoxifen resistance in breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Growth factor activation of the phosphatidylinositol 3-kinase (PI3K)-AKT pathway has been shown to activate the estrogen receptor (ER) alpha and to mediate tamoxifen resistance in breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Growth factor activation of the phosphatidylinositol 3-kinase (PI3K)-AKT pathway has been shown to activate the estrogen receptor (ER) alpha and to mediate tamoxifen resistance in breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP567421.RARWT0fAMQfVxzRPRvGB8CJgGV7FwsfbiaxlsexOtdnAw130_assertion description "[Growth factor activation of the phosphatidylinositol 3-kinase (PI3K)-AKT pathway has been shown to activate the estrogen receptor (ER) alpha and to mediate tamoxifen resistance in breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP567421.RARWT0fAMQfVxzRPRvGB8CJgGV7FwsfbiaxlsexOtdnAw130_provenance.
• NP567411.RAss2-bmF9z5YaJ2MVGKZUsEdLjnjm5iFn4xae5-UBAfY130_assertion description "[Growth factor activation of the phosphatidylinositol 3-kinase (PI3K)-AKT pathway has been shown to activate the estrogen receptor (ER) alpha and to mediate tamoxifen resistance in breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP567411.RAss2-bmF9z5YaJ2MVGKZUsEdLjnjm5iFn4xae5-UBAfY130_provenance.
• NP567412.RAkPuAXmIWpXilXn4HRm97zK_T8ZryIUzk1V-9Q0WSSR0130_assertion description "[Growth factor activation of the phosphatidylinositol 3-kinase (PI3K)-AKT pathway has been shown to activate the estrogen receptor (ER) alpha and to mediate tamoxifen resistance in breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP567412.RAkPuAXmIWpXilXn4HRm97zK_T8ZryIUzk1V-9Q0WSSR0130_provenance.
• NP567419.RAld0chRqI0VRwV4zTqpPq3tA-miiycZemehpD3zMV8WM130_assertion description "[Growth factor activation of the phosphatidylinositol 3-kinase (PI3K)-AKT pathway has been shown to activate the estrogen receptor (ER) alpha and to mediate tamoxifen resistance in breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP567419.RAld0chRqI0VRwV4zTqpPq3tA-miiycZemehpD3zMV8WM130_provenance.
• NP567408.RA8oUiLwifdypXdMtdxtKUpCtkdlle7RVD_G5rsW7DUa4130_assertion description "[Growth factor activation of the phosphatidylinositol 3-kinase (PI3K)-AKT pathway has been shown to activate the estrogen receptor (ER) alpha and to mediate tamoxifen resistance in breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP567408.RA8oUiLwifdypXdMtdxtKUpCtkdlle7RVD_G5rsW7DUa4130_provenance.
• NP567413.RA5wpewAe-rL0vlOdfzxl6C6P8ni2PWT6lHXhyWdJHYu0130_assertion description "[Growth factor activation of the phosphatidylinositol 3-kinase (PI3K)-AKT pathway has been shown to activate the estrogen receptor (ER) alpha and to mediate tamoxifen resistance in breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP567413.RA5wpewAe-rL0vlOdfzxl6C6P8ni2PWT6lHXhyWdJHYu0130_provenance.
• NP567418.RA1S2aSgLzMDpQhFp1VVySZ8VoiU3JdAR_XqCalFG4QA0130_assertion description "[Growth factor activation of the phosphatidylinositol 3-kinase (PI3K)-AKT pathway has been shown to activate the estrogen receptor (ER) alpha and to mediate tamoxifen resistance in breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP567418.RA1S2aSgLzMDpQhFp1VVySZ8VoiU3JdAR_XqCalFG4QA0130_provenance.
• NP567420.RA9mnI8dtfklDLVcPvTeN0JsUKv2OdraQJbVvABnmETNE130_assertion description "[Growth factor activation of the phosphatidylinositol 3-kinase (PI3K)-AKT pathway has been shown to activate the estrogen receptor (ER) alpha and to mediate tamoxifen resistance in breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP567420.RA9mnI8dtfklDLVcPvTeN0JsUKv2OdraQJbVvABnmETNE130_provenance.